Acute Eosinophilic Pneumonia Secondary to Daptomycin

Daptomycin is an antimicrobial agent with activity against gram-positive bacteria that is usually reserved for severe infections. Acute eosinophilic pneumonia (AEP) is an increasingly rare side effect that can manifest after its use. Our patient is a 79-year-old male who was admitted for a left tota...

Descripción completa

Detalles Bibliográficos
Autores principales: Somoza-Cano, Francisco J, Makadia, Austin, Cruz-Peralta, Massiel P, Zakarna, Lara, Demyda, Eleonora, Al Armashi, Abdul Rahman, Patell, Kanchi, Altaqi, Basel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658045/
https://www.ncbi.nlm.nih.gov/pubmed/34926005
http://dx.doi.org/10.7759/cureus.19403
_version_ 1784612640730906624
author Somoza-Cano, Francisco J
Makadia, Austin
Cruz-Peralta, Massiel P
Zakarna, Lara
Demyda, Eleonora
Al Armashi, Abdul Rahman
Patell, Kanchi
Altaqi, Basel
author_facet Somoza-Cano, Francisco J
Makadia, Austin
Cruz-Peralta, Massiel P
Zakarna, Lara
Demyda, Eleonora
Al Armashi, Abdul Rahman
Patell, Kanchi
Altaqi, Basel
author_sort Somoza-Cano, Francisco J
collection PubMed
description Daptomycin is an antimicrobial agent with activity against gram-positive bacteria that is usually reserved for severe infections. Acute eosinophilic pneumonia (AEP) is an increasingly rare side effect that can manifest after its use. Our patient is a 79-year-old male who was admitted for a left total knee arthroplasty infection. After daptomycin was started, he developed AEP. The offending agent was stopped, the appropriate medical treatment was given, and his symptoms significantly improved. This case illustrates an uncommon side effect of daptomycin. Prompt medical recognition is paramount for medication discontinuation and adequate medical care.
format Online
Article
Text
id pubmed-8658045
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-86580452021-12-17 Acute Eosinophilic Pneumonia Secondary to Daptomycin Somoza-Cano, Francisco J Makadia, Austin Cruz-Peralta, Massiel P Zakarna, Lara Demyda, Eleonora Al Armashi, Abdul Rahman Patell, Kanchi Altaqi, Basel Cureus Internal Medicine Daptomycin is an antimicrobial agent with activity against gram-positive bacteria that is usually reserved for severe infections. Acute eosinophilic pneumonia (AEP) is an increasingly rare side effect that can manifest after its use. Our patient is a 79-year-old male who was admitted for a left total knee arthroplasty infection. After daptomycin was started, he developed AEP. The offending agent was stopped, the appropriate medical treatment was given, and his symptoms significantly improved. This case illustrates an uncommon side effect of daptomycin. Prompt medical recognition is paramount for medication discontinuation and adequate medical care. Cureus 2021-11-09 /pmc/articles/PMC8658045/ /pubmed/34926005 http://dx.doi.org/10.7759/cureus.19403 Text en Copyright © 2021, Somoza-Cano et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Somoza-Cano, Francisco J
Makadia, Austin
Cruz-Peralta, Massiel P
Zakarna, Lara
Demyda, Eleonora
Al Armashi, Abdul Rahman
Patell, Kanchi
Altaqi, Basel
Acute Eosinophilic Pneumonia Secondary to Daptomycin
title Acute Eosinophilic Pneumonia Secondary to Daptomycin
title_full Acute Eosinophilic Pneumonia Secondary to Daptomycin
title_fullStr Acute Eosinophilic Pneumonia Secondary to Daptomycin
title_full_unstemmed Acute Eosinophilic Pneumonia Secondary to Daptomycin
title_short Acute Eosinophilic Pneumonia Secondary to Daptomycin
title_sort acute eosinophilic pneumonia secondary to daptomycin
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8658045/
https://www.ncbi.nlm.nih.gov/pubmed/34926005
http://dx.doi.org/10.7759/cureus.19403
work_keys_str_mv AT somozacanofranciscoj acuteeosinophilicpneumoniasecondarytodaptomycin
AT makadiaaustin acuteeosinophilicpneumoniasecondarytodaptomycin
AT cruzperaltamassielp acuteeosinophilicpneumoniasecondarytodaptomycin
AT zakarnalara acuteeosinophilicpneumoniasecondarytodaptomycin
AT demydaeleonora acuteeosinophilicpneumoniasecondarytodaptomycin
AT alarmashiabdulrahman acuteeosinophilicpneumoniasecondarytodaptomycin
AT patellkanchi acuteeosinophilicpneumoniasecondarytodaptomycin
AT altaqibasel acuteeosinophilicpneumoniasecondarytodaptomycin